These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 23922928)

  • 1. Ectopic Runx1 expression rescues Tal-1-deficiency in the generation of primitive and definitive hematopoiesis.
    Tornack J; Seiler K; Grützkau A; Grün JR; Onodera M; Melchers F; Tsuneto M
    PLoS One; 2013; 8(7):e70116. PubMed ID: 23922928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo.
    Webber BR; Iacovino M; Choi SH; Tolar J; Kyba M; Blazar BR
    Blood; 2013 Oct; 122(17):2978-86. PubMed ID: 24030384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation.
    Goardon N; Schuh A; Hajar I; Ma X; Jouault H; Dzierzak E; Roméo PH; Maouche-Chrétien L
    Blood; 2002 Jul; 100(2):491-500. PubMed ID: 12091340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of endoglin overexpression during embryoid body development.
    Baik J; Borges L; Magli A; Thatava T; Perlingeiro RC
    Exp Hematol; 2012 Oct; 40(10):837-46. PubMed ID: 22728030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCL/tal-1-dependent process determines a competence to select the definitive hematopoietic lineage prior to endothelial differentiation.
    Endoh M; Ogawa M; Orkin S; Nishikawa S
    EMBO J; 2002 Dec; 21(24):6700-8. PubMed ID: 12485991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-24 is required for hematopoietic differentiation of mouse embryonic stem cells.
    Roy L; Bikorimana E; Lapid D; Choi H; Nguyen T; Dahl R
    PLoS Genet; 2015 Jan; 11(1):e1004959. PubMed ID: 25634354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression.
    Ferreira R; Spensberger D; Silber Y; Dimond A; Li J; Green AR; Göttgens B
    Mol Cell Biol; 2013 Mar; 33(6):1254-66. PubMed ID: 23319051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Scl in mesoderm rescues hematopoiesis in the absence of Oct-4.
    Kong KY; Williamson EA; Rogers JH; Tran T; Hromas R; Dahl R
    Blood; 2009 Jul; 114(1):60-3. PubMed ID: 19321862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of hemangioblast development.
    Lacaud G; Robertson S; Palis J; Kennedy M; Keller G
    Ann N Y Acad Sci; 2001 Jun; 938():96-107; discussion 108. PubMed ID: 11458531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation.
    Cammenga J; Niebuhr B; Horn S; Bergholz U; Putz G; Buchholz F; Löhler J; Stocking C
    Cancer Res; 2007 Jan; 67(2):537-45. PubMed ID: 17234761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
    Hoang T; Lambert JA; Martin R
    Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
    Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
    Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploinsufficiency of Runx1 results in the acceleration of mesodermal development and hemangioblast specification upon in vitro differentiation of ES cells.
    Lacaud G; Kouskoff V; Trumble A; Schwantz S; Keller G
    Blood; 2004 Feb; 103(3):886-9. PubMed ID: 14525762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
    Miller JD; Stacy T; Liu PP; Speck NA
    Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse.
    Ou X; Chae HD; Wang RH; Shelley WC; Cooper S; Taylor T; Kim YJ; Deng CX; Yoder MC; Broxmeyer HE
    Blood; 2011 Jan; 117(2):440-50. PubMed ID: 20966168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.
    Ran D; Shia WJ; Lo MC; Fan JB; Knorr DA; Ferrell PI; Ye Z; Yan M; Cheng L; Kaufman DS; Zhang DE
    Blood; 2013 Apr; 121(15):2882-90. PubMed ID: 23372166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(C)-Binding Protein Pcbp2 Enables Differentiation of Definitive Erythropoiesis by Directing Functional Splicing of the Runx1 Transcript.
    Ghanem LR; Kromer A; Silverman IM; Ji X; Gazzara M; Nguyen N; Aguilar G; Martinelli M; Barash Y; Liebhaber SA
    Mol Cell Biol; 2018 Aug; 38(16):. PubMed ID: 29866654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis.
    Sroczynska P; Lancrin C; Kouskoff V; Lacaud G
    Blood; 2009 Dec; 114(26):5279-89. PubMed ID: 19858498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages.
    Porcher C; Swat W; Rockwell K; Fujiwara Y; Alt FW; Orkin SH
    Cell; 1996 Jul; 86(1):47-57. PubMed ID: 8689686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo.
    Mikkola HK; Fujiwara Y; Schlaeger TM; Traver D; Orkin SH
    Blood; 2003 Jan; 101(2):508-16. PubMed ID: 12393529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.